entity

suvorexant

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about suvorexant: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
0Hypotheses
1Analyses
3Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Suvorexant for Neurodegeneration

therapeutic · 1789 words

Outgoing (3)

TargetRelationTypeStr
HCRTR1inhibitsprotein0.95
HCRTR2inhibitsprotein0.95
DEMENTIAassociated_withdisease0.45

Incoming (1)

SourceRelationTypeStr
BREXPIPRAZOLEassociated_withdrug0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Perivascular spaces and glymphatic clearance failure in AD

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying perivascular spaces and glymphatic clearance

closed · Rounds: 4 · Score: 0.93 · 2026-04-01

Related Research

Hypotheses and analyses mentioning suvorexant in their description or question text

No additional research found